Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways
Authors
Keywords
-
Journal
CELLULAR ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-04
DOI
10.1007/s13402-023-00891-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2023
- (2023) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery
- (2023) Luigi Carlo Turco et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Nuclear S6K1 regulates cAMP-responsive element-dependent gene transcription through activation of mTOR signal pathway
- (2022) Ye Ji Jeon et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clinicopathological characteristics and survival outcomes in human papillomavirus independent cervical cancer: a propensity score matched analysis
- (2022) Danqing Li et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review
- (2022) Riccardo Di Fiore et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Should screening for cervical cancer go to primary human papillomavirus testing and eliminate cytology?
- (2022) Mohammed Amer Swid et al. MODERN PATHOLOGY
- HIF-1α Regulates the Progression of Cervical Cancer by Targeting YAP/TAZ
- (2022) Azierguli Abudoukerimu et al. Journal of Oncology
- Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer
- (2022) Ping Yang et al. Frontiers in Oncology
- Cervical cancer therapies: Current challenges and future perspectives
- (2022) Carly A. Burmeister et al. Tumour Virus Research
- Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis
- (2022) Marc Arbyn et al. LANCET ONCOLOGY
- Human papillomavirus targets the YAP1-LATS2 feedback loop to drive cervical cancer development
- (2022) Cong Huang et al. ONCOGENE
- Use of Single Cell Transcriptomic Techniques to Study the Role of High-Risk Human Papillomavirus Infection in Cervical Cancer
- (2022) Lingzhang Meng et al. Frontiers in Immunology
- False Negative Results in Cervical Cancer Screening—Risks, Reasons and Implications for Clinical Practice and Public Health
- (2022) Anna Macios et al. Diagnostics
- Pin1/ YAP pathway mediates matrix stiffness‐induced epithelial–mesenchymal transition driving cervical cancer metastasis via a non‐Hippo mechanism
- (2022) Long Yang et al. Bioengineering & Translational Medicine
- FBXO39 predicts poor prognosis and correlates with tumor progression in cervical squamous cell carcinoma
- (2022) Yanru Yang et al. PATHOLOGY RESEARCH AND PRACTICE
- Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy
- (2021) Ping Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A novel era of cancer/testis antigen in cancer immunotherapy
- (2021) Xiaoyan Meng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Reduction‐Sensitive Fluorinated‐Pt(IV) Universal Transfection Nanoplatform Facilitating CT45‐Targeted CRISPR/dCas9 Activation for Synergistic and Individualized Treatment of Ovarian Cancer
- (2021) Hongtong Lu et al. Small
- CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through β-catenin
- (2021) Mingxin Wen et al. Cell Death & Disease
- Increased expression of TAZ and associated upregulation of PD-L1 in cervical cancer
- (2021) Yanyan Han et al. Cancer Cell International
- Hexokinases 2 promoted cell motility and distant metastasis by elevating fibronectin through Akt1/p-Akt1 in cervical cancer cells
- (2021) Qian Chen et al. Cancer Cell International
- Human papillomavirus-independent cervical cancer
- (2021) Andreina Fernandes et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Impact of hypoxia on cervical cancer outcomes
- (2021) Anubhav Datta et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Epigenetic approaches for cervical neoplasia screening (Review)
- (2021) Adrian Albulescu et al. Experimental and Therapeutic Medicine
- NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression
- (2021) Lijun Wang et al. Frontiers in Oncology
- The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapy
- (2020) Bo Yang et al. CELL DEATH AND DIFFERENTIATION
- High Expression of Integrin α3 Predicts Poor Prognosis and Promotes Tumor Metastasis and Angiogenesis by Activating the c-Src/Extracellular Signal-Regulated Protein Kinase/Focal Adhesion Kinase Signaling Pathway in Cervical Cancer
- (2020) Qiqiao Du et al. Frontiers in Oncology
- Correction of the tumor suppressor Salvador homolog-1 deficiency in tumors by lycorine as a new strategy in lung cancer therapy
- (2020) Zhe Zhao et al. Cell Death & Disease
- Redox Regulation of NOX Isoforms on FAK(Y397)/SRC(Y416) Phosphorylation Driven Epithelial-to-Mesenchymal Transition in Malignant Cervical Epithelial Cells
- (2020) Young Mee Kim et al. Cells
- A Comprehensive Review on Crosstalk of Human Papilloma Virus oncoproteins and developmental/self-renewal pathways during the pathogenesis of uterine cervical cancer
- (2020) Afza Ahmad et al. CURRENT MOLECULAR MEDICINE
- Molecular landscape of recurrent cervical cancer
- (2020) Divya Adiga et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Fibronectin promotes cervical cancer tumorigenesis through activating FAK signaling pathway
- (2019) Yuzhen Zhou et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathway
- (2018) Ping Yang et al. CANCER LETTERS
- Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer
- (2018) Fabian Coscia et al. CELL
- Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
- (2018) Olga Gordeeva SEMINARS IN CANCER BIOLOGY
- CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway
- (2017) Feng Tang et al. Molecular Medicine Reports
- Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis
- (2017) Mei Chen et al. PLoS One
- DNA hypomethylation-mediated activation ofCancer/Testis Antigen 45(CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer
- (2015) Wa Zhang et al. Epigenetics
- CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis
- (2014) B Shang et al. Cell Death & Disease
- Down-regulation of the cancer/testis antigen 45 (CT45) is associated with altered tumor cell morphology, adhesion and migration
- (2013) Anja Koop et al. Cell Communication and Signaling
- Cyclic AMP-Response Element Regulated Cell Cycle Arrests in Cancer Cells
- (2013) Ping Wang et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation